Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Ted M. Dawson et al.|British Journal of Pharmacology|2017Cited by 210
Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literatureMarc Léone, Claude Martin, Pierre Asfar et al.|Critical Care|2015Cited by 207
A CRHR1 antagonist prevents synaptic loss and memory deficits in a trauma-induced delirium-like syndromeSilvia Cursano, Tobias M. Boeckers, Chiara R. Battaglia et al.|Molecular Psychiatry|2020Cited by 38
Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challengeMartin Wepler, Warren M. Zapol, Arkadi Beloiartsev et al.|American Journal of Physiology-Lung Cellular and Molecular Physiology|2016Cited by 16